PATEL DINESH V PH D
Insider CIK 1120477 · PTGX President and CEO, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-09-10 | 2026-09-10 | 7,278 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-09-10 | 2026-09-10 | 7,278 | $144.10 | $1.05M | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-09-10 | 2026-09-10 | 7,278 | $21.58 | $157.1K | 530,246 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-09-10 | 2026-09-10 | 7,278 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-09-10 | 2026-09-10 | 7,278 | $144.10 | $1.05M | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-09-10 | 2026-09-10 | 7,278 | $21.58 | $157.1K | 530,246 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-09-09 | 2026-09-10 | 63,548 | — | $0 | 7,278 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-09-09 | 2026-09-10 | 63,548 | $21.58 | $1.37M | 586,516 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-09-09 | 2026-09-10 | 63,548 | $146.18 | $9.29M | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-09-09 | 2026-09-10 | 63,548 | — | $0 | 7,278 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-09-09 | 2026-09-10 | 63,548 | $146.18 | $9.29M | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-09-09 | 2026-09-10 | 63,548 | $21.58 | $1.37M | 586,516 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-09-08 | 2026-09-10 | 54,174 | — | $0 | 70,826 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-09-08 | 2026-09-10 | 54,174 | $21.58 | $1.17M | 577,142 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-09-08 | 2026-09-10 | 54,174 | $145.87 | $7.90M | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-09-08 | 2026-09-10 | 54,174 | — | $0 | 70,826 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-09-08 | 2026-09-10 | 54,174 | $145.87 | $7.90M | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-09-08 | 2026-09-10 | 54,174 | $21.58 | $1.17M | 577,142 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2026-09-03 | 2026-09-08 | 510 | — | $0 | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2026-09-03 | 2026-09-08 | 510 | — | $0 | 522,968 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-08-11 | 2026-08-12 | 34,239 | — | $0 | 125,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-08-11 | 2026-08-12 | 34,239 | $21.58 | $738.9K | 557,717 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-08-11 | 2026-08-12 | 34,239 | $148.52 | $5.09M | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-08-11 | 2026-08-12 | 34,239 | — | $0 | 125,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-08-11 | 2026-08-12 | 34,239 | $148.52 | $5.09M | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-08-11 | 2026-08-12 | 34,239 | $21.58 | $738.9K | 557,717 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-08-10 | 2026-08-12 | 65,761 | — | $0 | 159,239 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-08-10 | 2026-08-12 | 65,761 | $149.11 | $9.81M | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-08-10 | 2026-08-12 | 65,761 | $21.58 | $1.42M | 589,239 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-08-10 | 2026-08-12 | 65,761 | — | $0 | 159,239 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-08-10 | 2026-08-12 | 65,761 | $149.11 | $9.81M | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-08-10 | 2026-08-12 | 65,761 | $21.58 | $1.42M | 589,239 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-05-12 | 2026-05-12 | 75,000 | — | $0 | 225,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-05-12 | 2026-05-14 | 75,000 | — | $0 | 225,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-05-12 | 2026-05-12 | 75,000 | $100.12 | $7.51M | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-05-12 | 2026-05-12 | 75,000 | $21.58 | $1.62M | 598,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-05-12 | 2026-05-14 | 75,000 | $21.58 | $1.62M | 598,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-05-12 | 2026-05-14 | 75,000 | $100.12 | $7.51M | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2026-04-23 | 2026-04-24 | 1,460 | — | $0 | 523,478 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-03-25 | 2026-03-25 | 54,641 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-03-25 | 2026-03-25 | 54,641 | $8.58 | $468.8K | 579,579 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-03-25 | 2026-03-25 | 54,641 | $101.00 | $5.52M | 524,938 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-03-24 | 2026-03-25 | 59 | — | $0 | 54,641 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-03-24 | 2026-03-25 | 59 | $101.00 | $6.0K | 524,938 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-03-24 | 2026-03-25 | 59 | $8.58 | $506 | 524,997 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2026-03-23 | 2026-03-25 | 50,000 | — | $0 | 524,938 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-27 | 2026-01-27 | 4,068 | — | $0 | 300,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-27 | 2026-01-27 | 4,068 | $21.58 | $87.8K | 578,573 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-27 | 2026-01-27 | 4,068 | $83.19 | $338.4K | 574,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-26 | 2026-01-27 | 10,685 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-26 | 2026-01-27 | 14,205 | — | $0 | 304,068 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-26 | 2026-01-27 | 14,205 | $84.05 | $1.19M | 574,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-26 | 2026-01-27 | 14,205 | $21.58 | $306.5K | 588,710 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-26 | 2026-01-27 | 10,685 | $84.00 | $897.5K | 574,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-26 | 2026-01-27 | 10,685 | $4.21 | $45.0K | 585,190 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-23 | 2026-01-27 | 19,315 | — | $0 | 10,685 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-23 | 2026-01-27 | 19,315 | $84.59 | $1.63M | 574,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-23 | 2026-01-27 | 19,315 | $4.21 | $81.3K | 593,820 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2026-01-23 | 2026-01-27 | 6,000 | — | $0 | 574,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-01-20 | 2026-01-21 | 34,438 | $82.48 | $2.84M | 580,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2026-01-02 | 2026-01-06 | 120,200 | — | $0 | 120,200 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2026-01-02 | 2026-01-06 | 95,400 | — | $0 | 614,943 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2025-11-21 | 2025-11-24 | 440 | — | $0 | 519,543 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2025-09-16 | 2025-09-18 | 620 | — | $0 | 519,983 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-07-25 | 2025-07-28 | 10,415 | $54.78 | $570.5K | 520,603 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-07-23 | 2025-07-23 | 17,520 | $54.79 | $959.9K | 531,018 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-07-22 | 2025-07-23 | 22,065 | $55.05 | $1.21M | 548,538 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2025-07-21 | 2025-07-23 | 25,000 | — | $0 | 583,462 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-07-21 | 2025-07-23 | 12,859 | $54.86 | $705.4K | 570,603 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2025-07-16 | 2025-07-18 | 5,000 | — | $0 | 558,462 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2025-06-16 | 2025-06-17 | 685 | — | $0 | 562,905 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2025-06-13 | 2025-06-17 | 670 | — | $0 | 563,590 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2025-03-05 | 2025-03-05 | 24,000 | — | $0 | 30,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2025-03-05 | 2025-03-05 | 24,000 | $4.21 | $101.0K | 564,260 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2025-02-19 | 2025-02-20 | 5,359 | $38.18 | $204.6K | 540,260 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2025-01-15 | 2025-01-17 | 12,636 | — | $0 | 545,619 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2025-01-02 | 2025-01-06 | 181,472 | — | $0 | 181,472 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2025-01-02 | 2025-01-06 | 149,800 | — | $0 | 558,255 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-26 | 2024-11-27 | 21,480 | $46.25 | $993.5K | 408,455 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-11-25 | 2024-11-27 | 1,727 | — | $0 | 318,273 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2024-11-25 | 2024-11-27 | 7,000 | — | $0 | 428,208 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-11-25 | 2024-11-27 | 78,520 | $46.96 | $3.69M | 435,208 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-11-25 | 2024-11-27 | 1,727 | $21.58 | $37.3K | 429,935 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2024-11-19 | 2024-11-21 | 1,000 | — | $0 | 513,415 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2024-06-13 | 2024-06-17 | 1,000 | — | $0 | 514,415 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-06-07 | 2024-06-11 | 35,000 | $35.19 | $1.23M | 515,415 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-04-01 | 2024-04-02 | 25,000 | $28.31 | $707.8K | 549,590 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2024-03-01 | 2024-03-01 | 30,000 | $31.62 | $948.6K | 574,590 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2024-02-26 | 2024-02-28 | 10,915 | $29.53 | $322.3K | 604,590 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2024-02-15 | 2024-02-20 | 3,717 | $28.23 | $104.9K | 615,505 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2024-01-02 | 2024-01-04 | 315,250 | — | $0 | 315,250 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2024-01-02 | 2024-01-04 | 84,875 | — | $0 | 619,222 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2023-12-13 | 2023-12-15 | 75,000 | $20.08 | $1.51M | 534,347 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2023-10-18 | 2023-10-19 | 6,000 | — | $0 | 54,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2023-10-18 | 2023-10-19 | 6,000 | $4.21 | $25.3K | 609,347 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2023-05-31 | 2023-06-02 | 30,000 | — | $0 | 615,111 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2023-05-31 | 2023-06-02 | 12,165 | $26.07 | $317.1K | 602,946 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2023-02-22 | 2023-06-02 | 10,000 | — | $0 | 583,448 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2023-01-16 | 2023-01-18 | 600,000 | — | $0 | 600,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2022-12-28 | 2023-01-18 | 3,116 | — | $0 | 598,096 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-08-23 | 2022-08-24 | 20,000 | — | $0 | 60,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-08-23 | 2022-08-24 | 20,000 | $4.21 | $84.2K | 604,048 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2022-05-04 | 2023-01-18 | 3,000 | — | $0 | 581,048 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-05-04 | 2022-05-04 | 15,742 | — | $0 | 80,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-05-04 | 2022-05-04 | 15,742 | $4.21 | $66.3K | 584,048 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-04-26 | 2022-04-26 | 30,000 | — | $0 | 95,742 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-04-26 | 2022-04-26 | 30,000 | $4.21 | $126.3K | 568,306 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2022-04-14 | 2022-04-14 | 34,087 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2022-04-14 | 2022-04-14 | 34,087 | $1.89 | $64.4K | 537,847 | SEC↗ |
| PTGX Protagonist Therapeutics, | F Tax w/h | 2022-02-28 | 2022-03-02 | 4,648 | $24.28 | $112.9K | 503,760 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-02-15 | 2022-02-17 | 187,500 | — | $0 | 187,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2022-02-15 | 2022-02-17 | 31,250 | — | $0 | 508,408 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2021-12-21 | 2021-12-23 | 15,000 | $32.14 | $482.1K | 477,158 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2021-09-21 | 2021-09-21 | 40,000 | — | $0 | 125,742 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2021-09-21 | 2021-09-21 | 40,000 | $4.21 | $168.4K | 492,158 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-02-26 | 2021-02-26 | 225,000 | — | $0 | 225,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2021-02-26 | 2021-02-26 | 25,000 | — | $0 | 451,144 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2021-01-19 | 2021-01-20 | 13,000 | — | $0 | 165,742 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2021-01-19 | 2021-01-20 | 24,846 | $24.60 | $611.2K | 426,144 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2021-01-19 | 2021-01-20 | 13,000 | $4.21 | $54.7K | 450,990 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2020-04-29 | 2020-05-01 | 2,000 | — | $0 | 437,990 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2020-03-20 | 2020-03-23 | 10,000 | — | $0 | 34,087 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2020-03-20 | 2020-03-23 | 10,000 | $1.89 | $18.9K | 439,990 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2020-03-12 | 2020-03-13 | 18,344 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2020-03-12 | 2020-03-13 | 18,344 | $1.16 | $21.3K | 429,990 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-02-28 | 2020-02-28 | 235,000 | — | $0 | 235,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2019-12-03 | 2019-12-03 | 10,000 | $5.55 | $55.5K | 389,824 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2019-12-03 | 2019-12-03 | 20,000 | $5.65 | $113.0K | 409,824 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2019-11-26 | 2019-11-27 | 4,000 | — | $0 | 18,343 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2019-11-26 | 2019-11-27 | 4,000 | $1.16 | $4.6K | 379,824 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-08-06 | 2019-08-08 | 10,792 | $8.85 | $95.5K | 374,792 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-03-01 | 2019-03-04 | 2,183 | $8.03 | $17.5K | 383,831 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-02-28 | 2019-03-04 | 172,500 | — | $0 | 172,500 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2019-02-28 | 2019-03-04 | 28,750 | — | $0 | 386,014 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-02-06 | 2019-02-08 | 777 | $8.10 | $6.3K | 367,396 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2019-02-06 | 2019-02-08 | 10,132 | $7.71 | $78.1K | 357,264 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2019-01-11 | 2019-01-14 | 22,344 | — | $0 | 22,343 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2019-01-11 | 2019-01-14 | 22,344 | $1.16 | $25.9K | 368,173 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-08-15 | 2018-08-17 | 54,700 | — | $0 | 54,700 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-08-15 | 2018-08-17 | 82,050 | — | $0 | 345,829 | SEC↗ |
| PTGX Protagonist Therapeutics, | G Gift | 2018-07-12 | 2018-07-13 | 2,000 | — | $0 | 263,779 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2018-05-10 | 2018-05-11 | 13,516 | — | $0 | 44,687 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2018-05-10 | 2018-05-11 | 13,516 | $1.16 | $15.7K | 265,779 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2018-04-02 | 2018-04-03 | 20,000 | — | $0 | 58,203 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2018-04-02 | 2018-04-03 | 20,000 | $1.16 | $23.2K | 252,263 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2018-03-26 | 2018-03-28 | 11,298 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2018-03-26 | 2018-03-28 | 11,298 | $0.87 | $9.8K | 232,263 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-02-28 | 2018-03-02 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2018-02-28 | 2018-03-02 | 25,000 | — | $0 | 219,259 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-12-21 | 2017-12-21 | 8,210 | — | $0 | 44,087 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-12-21 | 2017-12-21 | 8,210 | $19.56 | $160.6K | 190,437 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-12-21 | 2017-12-21 | 8,210 | $1.89 | $15.5K | 198,647 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-12-20 | 2017-12-20 | 1,790 | — | $0 | 52,297 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-12-20 | 2017-12-20 | 1,790 | $1.89 | $3.4K | 192,227 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2017-12-20 | 2017-12-20 | 1,790 | $19.55 | $35.0K | 190,437 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-05-09 | 2017-05-10 | 19,099 | — | $0 | 78,203 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-05-09 | 2017-05-10 | 19,099 | $1.16 | $22.2K | 190,437 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-04-06 | 2017-04-07 | 20,000 | — | $0 | 97,302 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-04-06 | 2017-04-07 | 20,000 | $1.16 | $23.2K | 171,338 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2017-03-10 | 2017-03-13 | 16,362 | — | $0 | 11,297 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2017-03-10 | 2017-03-13 | 16,362 | $0.87 | $14.2K | 151,338 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2016-10-11 | 2016-10-13 | 320,000 | — | $0 | 320,000 | SEC↗ |